Abstract
Ulcerative colitis (UC) is an inflammatory bowel disease that affects the mucosa of the colon, resulting in severe inflammation and ulcers. Genistein is a polyphenolic isoflavone present in several vegetables, such as soybeans and fava beans. Therefore, we conducted the following study to determine the therapeutic effects of genistein on UC in rats by influencing antioxidant activity and mitochondrial biogenesis and the subsequent effects on the apoptotic pathway. UC was induced in rats by single intracolonic administration of 2 ml of 4% acetic acid. Then, UC rats were treated with 25-mg/kg genistein. Colon samples were obtained to assess the gene and protein expression of nuclear factor erythroid 2-related factor-2 (Nrf2), heme oxygenase-1 (HO-1), peroxisome proliferator-activated receptor-gamma coactivator (PGC-1), mitochondrial transcription factor A (TFAM), B-cell lymphoma 2 (BCL2), BCL2-associated X (BAX), caspase-3, caspase-8, and caspase-9. In addition, colon sections were stained with hematoxylin/eosin to investigate the cell structure. The microimages of UC rats revealed inflammatory cell infiltration, hemorrhage, and the destruction of intestinal glands, and these effects were improved by treatment with genistein. Finally, treatment with genistein significantly increased the expression of PGC-1, TFAM, Nrf2, HO-1, and BCL2 and reduced the expression of BAX, caspase-3, caspase-8, and caspase-9. In conclusion, genistein exerted therapeutic effects against UC in rats. This therapeutic activity involved enhancing antioxidant activity and increasing mitochondrial biogenesis, which reduced cell apoptosis.
Similar content being viewed by others
Data availability
The datasets generated during and/or analyzed during the current study are available from the corresponding author on reasonable request.
References
Adams SM, Bornemann PH (2013) Ulcerative colitis. Am Fam Physician 87:699–705
Ordas I, Eckmann L, Talamini M, Baumgart DC, Sandborn WJ (2012) Ulcerative colitis. Lancet 380:1606–1619. https://doi.org/10.1016/S0140-6736(12)60150-0
Armuzzi A, Liguori G (2021) Quality of life in patients with moderate to severe ulcerative colitis and the impact of treatment: A narrative review. Dig Liver Dis 53:803–808. https://doi.org/10.1016/j.dld.2021.03.002
Colombel JF, Mahadevan U (2017) Inflammatory bowel disease 2017: innovations and changing paradigms. Gastroenterology 152:309–312. https://doi.org/10.1053/j.gastro.2016.12.004
Gardiner LJ, Carrieri AP, Bingham K, Macluskie G, Bunton D, McNeil M, Pyzer-Knapp EO (2022) Combining explainable machine learning, demographic and multi-omic data to inform precision medicine strategies for inflammatory bowel disease. PLoS ONE 17:e0263248. https://doi.org/10.1371/journal.pone.0263248
Billmeier U, Dieterich W, Neurath MF, Atreya R (2016) Molecular mechanism of action of anti-tumor necrosis factor antibodies in inflammatory bowel diseases. World J Gastroenterol 22:9300–9313. https://doi.org/10.3748/wjg.v22.i42.9300
Vermeire S, O’Byrne S, Keir M, Williams M, Lu TT, Mansfield JC, Lamb CA, Feagan BG, Panes J, Salas A, Baumgart DC, Schreiber S, Dotan I, Sandborn WJ, Tew GW, Luca D, Tang MT, Diehl L, Eastham-Anderson J, De Hertogh G, Perrier C, Egen JG, Kirby JA, van Assche G, Rutgeerts P (2014) Etrolizumab as induction therapy for ulcerative colitis: a randomised, controlled, phase 2 trial. Lancet 384:309–318. https://doi.org/10.1016/S0140-6736(14)60661-9
Zurba Y, Gros B, Shehab M (2023) Exploring the pipeline of novel therapies for inflammatory bowel disease; state of the art review. Biomedicines. https://doi.org/10.3390/biomedicines11030747
Papp K, Reich K, Leonardi CL, Kircik L, Chimenti S, Langley RG, Hu C, Stevens RM, Day RM, Gordon KB, Korman NJ, Griffiths CE (2015) Apremilast, an oral phosphodiesterase 4 (PDE4) inhibitor, in patients with moderate to severe plaque psoriasis: results of a phase III, randomized, controlled trial (Efficacy and Safety Trial Evaluating the Effects of Apremilast in Psoriasis [ESTEEM] 1). J Am Acad Dermatol 73:37–49. https://doi.org/10.1016/j.jaad.2015.03.049
Fernandez-Clotet A, Castro-Poceiro J, Panes J (2018) Tofacitinib for the treatment of ulcerative colitis. Expert Rev Clin Immunol 14:881–892. https://doi.org/10.1080/1744666X.2018.1532291
El-Far YM, Khodir AE, Emarah ZA, Ebrahim MA, Al-Gayyar MMH (2022) Chemopreventive and hepatoprotective effects of genistein via inhibition of oxidative stress and the versican/PDGF/PKC signaling pathway in experimentally induced hepatocellular carcinoma in rats by thioacetamide. Redox Rep 27:9–20. https://doi.org/10.1080/13510002.2022.2031515
Tanideh N, Sadeghi F, Amanat S, Firoozi D, Noorafshan A, Iraji A, Koohi-Hosseinabadi O (2020) Protection by pure and genistein fortified extra virgin olive oil, canola oil, and rice bran oil against acetic acid-induced ulcerative colitis in rats. Food Funct 11:860–870. https://doi.org/10.1039/c9fo01951k
Alattar A, Alshaman R, Al-Gayyar MMH (2022) Therapeutic effects of sulforaphane in ulcerative colitis: effect on antioxidant activity, mitochondrial biogenesis and DNA polymerization. Redox Rep 27:128–138. https://doi.org/10.1080/13510002.2022.2092378
Albalawi GA, Albalawi MZ, Alsubaie KT, Albalawi AZ, Elewa MAF, Hashem KS, Al-Gayyar MMH (2023) Curative effects of crocin in ulcerative colitis via modulating apoptosis and inflammation. Int Immunopharmacol 118:110138. https://doi.org/10.1016/j.intimp.2023.110138
Bagalagel A, Diri R, Noor A, Almasri D, Bakhsh HT, Kutbi HI, Al-Gayyar MMH (2022) Curative effects of fucoidan on acetic acid induced ulcerative colitis in rats via modulating aryl hydrocarbon receptor and phosphodiesterase-4. BMC Complement Med Ther 22:196. https://doi.org/10.1186/s12906-022-03680-4
Bagalagel A, Diri R, Noor A, Almasri D, Bakhsh HT, Kutbi HI, Al-Gayyar MMH (2022) The therapeutic effects of cycloastragenol in ulcerative colitis by modulating SphK/MIP-1alpha/miR-143 signalling. Basic Clin Pharmacol Toxicol 131:406–419. https://doi.org/10.1111/bcpt.13788
Bagalagel A, Diri R, Noor A, Almasri D, Bakhsh H, Kutbi HI, Al-Gayyar MM (2022) Evaluating the anticancer activity of blocking TNF type 1 receptors in thioacetamide-induced hepatocellular carcinoma in a rat model. Cureus 14:e32519. https://doi.org/10.7759/cureus.32519
Hassan HM, El-Kannishy SMH, Alattar A, Alshaman R, Hamdan AM, Al-Gayyar MMH (2021) Therapeutic effects of blocking beta-catenin against hepatocellular carcinoma-induced activation of inflammation, fibrosis and tumor invasion. Biomed Pharmacother. https://doi.org/10.1016/j.biopha.2021.111216
Sherif IO, Al-Gayyar MMH (2018) Oleuropein potentiates anti-tumor activity of cisplatin against HepG2 through affecting proNGF/NGF balance. Life Sci 198:87–93. https://doi.org/10.1016/j.lfs.2018.02.027
Xu Y, Shen J, Ran Z (2020) Emerging views of mitophagy in immunity and autoimmune diseases. Autophagy 16:3–17. https://doi.org/10.1080/15548627.2019.1603547
Keshavarzian A, Banan A, Farhadi A, Komanduri S, Mutlu E, Zhang Y, Fields JZ (2003) Increases in free radicals and cytoskeletal protein oxidation and nitration in the colon of patients with inflammatory bowel disease. Gut 52:720–728. https://doi.org/10.1136/gut.52.5.720
Du L, Ha C (2020) Epidemiology and Pathogenesis of Ulcerative Colitis. Gastroenterol Clin North Am 49:643–654. https://doi.org/10.1016/j.gtc.2020.07.005
Cagin YF, Parlakpinar H, Vardi N, Polat A, Atayan Y, Erdogan MA, Tanbek K (2016) Effects of dexpanthenol on acetic acid-induced colitis in rats. Exp Ther Med 12:2958–2964. https://doi.org/10.3892/etm.2016.3728
Cunningham KE, Vincent G, Sodhi CP, Novak EA, Ranganathan S, Egan CE, Stolz DB, Rogers MB, Firek B, Morowitz MJ, Gittes GK, Zuckerbraun BS, Hackam DJ, Mollen KP (2016) Peroxisome Proliferator-activated Receptor-gamma Coactivator 1-alpha (PGC1alpha) Protects against Experimental Murine Colitis. J Biol Chem 291:10184–10200. https://doi.org/10.1074/jbc.M115.688812
Reifen R, Levy E, Berkovich Z, Tirosh O (2015) Vitamin A exerts its antiinflammatory activities in colitis through preservation of mitochondrial activity. Nutrition 31:1402–1407. https://doi.org/10.1016/j.nut.2015.05.011
Shi Y, Dierckx A, Wanrooij PH, Wanrooij S, Larsson NG, Wilhelmsson LM, Falkenberg M, Gustafsson CM (2012) Mammalian transcription factor A is a core component of the mitochondrial transcription machinery. Proc Natl Acad Sci U S A 109:16510–16515. https://doi.org/10.1073/pnas.1119738109
Alizadeh R, Salehi O, Rezaeinezhad N, Hosseini SA (2023) The effect of high intensity interval training with genistein supplementation on mitochondrial function in the heart tissue of elderly rats. Exp Gerontol 171:112039. https://doi.org/10.1016/j.exger.2022.112039
Yao K, Zhang WW, Yao L, Yang S, Nie W, Huang F (2016) Carvedilol promotes mitochondrial biogenesis by regulating the PGC-1/TFAM pathway in human umbilical vein endothelial cells (HUVECs). Biochem Biophys Res Commun 470:961–966. https://doi.org/10.1016/j.bbrc.2016.01.089
Baskol G, Baskol M, Yurci A, Ozbakir O, Yucesoy M (2006) Serum paraoxonase 1 activity and malondialdehyde levels in patients with ulcerative colitis. Cell Biochem Funct 24:283–286. https://doi.org/10.1002/cbf.1224
Kurutas EB (2016) The importance of antioxidants which play the role in cellular response against oxidative/nitrosative stress: current state. Nutr J 15:71. https://doi.org/10.1186/s12937-016-0186-5
El-Fadl IA, HM and Mohamed MFA, (2022) Targeting endoplasmic reticulum stress, Nrf-2/HO-1, and NF-kappaB by myristicin and its role in attenuation of ulcerative colitis in rats. Life Sci 311:121187. https://doi.org/10.1016/j.lfs.2022.121187
Deng L, Guo H, Wang S, Liu X, Lin Y, Zhang R, Tan W (2022) The attenuation of chronic ulcerative colitis by (R)-salbutamol in repeated DSS-induced mice. Oxid Med Cell Longev 2022:9318721. https://doi.org/10.1155/2022/9318721
Mei Y, Wang Z, Zhang Y, Wan T, Xue J, He W, Luo Y, Xu Y, Bai X, Wang Q, Huang Y (2019) FA-97, a New synthetic caffeic acid phenethyl ester derivative, ameliorates DSS-induced colitis against oxidative stress by activating Nrf2/HO-1 pathway. Front Immunol 10:2969. https://doi.org/10.3389/fimmu.2019.02969
Tan Y, Zheng C (2018) Effects of alpinetin on intestinal barrier function, inflammation and oxidative stress in dextran sulfate sodium-induced ulcerative colitis mice. Am J Med Sci 355:377–386. https://doi.org/10.1016/j.amjms.2018.01.002
Li Y, Pan X, Yin M, Li C, Han L (2021) preventive effect of lycopene in dextran sulfate sodium-induced ulcerative colitis mice through the regulation of TLR4/TRIF/NF-kappaB signaling pathway and tight junctions. J Agric Food Chem 69:13500–13509. https://doi.org/10.1021/acs.jafc.1c05128
Holmes EW, Yong SL, Eiznhamer D, Keshavarzian A (1998) Glutathione content of colonic mucosa: evidence for oxidative damage in active ulcerative colitis. Dig Dis Sci 43:1088–1095. https://doi.org/10.1023/a:1018899222258
Vanden Braber NL, Novotny Nunez I, Bohl L, Porporatto C, Nazar FN, Montenegro MA, Correa SG (2018) Soy genistein administered in soluble chitosan microcapsules maintains antioxidant activity and limits intestinal inflammation. J Nutr Biochem 62:50–58. https://doi.org/10.1016/j.jnutbio.2018.08.009
Pool H, Campos-Vega R, Herrera-Hernandez MG, Garcia-Solis P, Garcia-Gasca T, Sanchez IC, Luna-Barcenas G, Vergara-Castaneda H (2018) Development of genistein-PEGylated silica hybrid nanomaterials with enhanced antioxidant and antiproliferative properties on HT29 human colon cancer cells. Am J Transl Res 10:2306–2323
Zhang P, Zhang X, Xiong P, Zhong C, Zhou Z, Jia B, Liu X (2022) Renshen Baidu powder attenuated intestinal inflammation and apoptosis in ulcerative colitis rats through the inhibition of PI3K/AKT/NF-kappaB signaling pathway. Evid Based Complement Alternat Med 2022:5234025. https://doi.org/10.1155/2022/5234025
Dudzinska E, Szymona K, Gil-Kulik P, Chomik P, Swistowska M, Gryzinska M, Kocki J (2019) Imbalance of controlled death in peripheral blood lymphocytes in crohn’s disease and ulcerative colitis. Medicina (Kaunas). https://doi.org/10.3390/medicina55060231
Kinra P, Turlapati S, Mehta A, Rai R (2005) Study of p53 and bcl-2 oncoproteins in ulcerative colitis with dysplasia. Med J Armed Forces India 61:125–129. https://doi.org/10.1016/S0377-1237(05)80006-1
Sun J, Zhang H, Guan L, Zhou H, Sun M (2015) Alpha-lipoic acid attenuates trinitrobenzene sulfonic acid-induced ulcerative colitis in mice. Int J Clin Exp Med 8:358–367
Siriviriyakul P, Werawatganon D, Phetnoo N, Somanawat K, Chatsuwan T, Klaikeaw N, Chayanupatkul M (2020) Genistein attenuated gastric inflammation and apoptosis in helicobacter pylori-induced gastropathy in rats. BMC Gastroenterol 20:410. https://doi.org/10.1186/s12876-020-01555-x
Liu Y, Wei W, Liang S, Fang H, Cao J (2022) Esculentoside A could attenuate apoptosis and inflammation in TNBS-induced ulcerative colitis via inhibiting the nuclear translocation of NF-kappaB. Ann Transl Med 10:771. https://doi.org/10.21037/atm-22-2675
Becker C, Watson AJ, Neurath MF (2013) Complex roles of caspases in the pathogenesis of inflammatory bowel disease. Gastroenterology 144:283–293. https://doi.org/10.1053/j.gastro.2012.11.035
Leal RF, Ayrizono Mde L, Milanski M, Fagundes JJ, Moraes JC, Meirelles LR, Velloso LA, Coy CS (2010) Detection of epithelial apoptosis in pelvic ileal pouches for ulcerative colitis and familial adenomatous polyposis. J Transl Med 8:11. https://doi.org/10.1186/1479-5876-8-11
Michael McClain R, Wolz E, Davidovich A, Pfannkuch F, Edwards JA, Bausch J (2006) Acute, subchronic and chronic safety studies with genistein in rats. Food Chem Toxicol 44:56–80. https://doi.org/10.1016/j.fct.2005.05.021
Kim IS (2021) Current perspectives on the beneficial effects of soybean isoflavones and their metabolites for humans. Antioxidants (Basel). https://doi.org/10.3390/antiox10071064
Acknowledgements
None
Funding
The authors declare that no funds, grants, or other support were received during the preparation of this manuscript.
Author information
Authors and Affiliations
Contributions
TSA, ZSA, ZNA, and FA were responsible for performing the biochemical analysis. MFE and KSH were responsible for performing the animal experiments. MFE and KSH performed pathological and immunohistochemistry analysis. TSA, ZSA, ZNA, and FA performed the statistical analysis. MMHA came up with the concept for the study and supervised the work. TSA, ZSA, ZNA, FA, MFE, and KSH helped develop and design the present study. All authors contributed to the writing of the manuscript and approved the final version.
Corresponding author
Ethics declarations
Competing interests
The authors have no relevant financial or non-financial interests to disclose.
Ethical approval
The work protocol was approved by Institutional Animal Care and Use Committee, Beni-Suef University (BSU-IACUC-022-356).
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Alharbi, T.S., Alshammari, Z.S., Alanzi, Z.N. et al. Therapeutic effects of genistein in experimentally induced ulcerative colitis in rats via affecting mitochondrial biogenesis. Mol Cell Biochem 479, 431–444 (2024). https://doi.org/10.1007/s11010-023-04746-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11010-023-04746-8